Stay updated on PD-L1+ Lung Cancer: Pembrolizumab vs Chemotherapy Clinical Trial
Sign up to get notified when there's something new on the PD-L1+ Lung Cancer: Pembrolizumab vs Chemotherapy Clinical Trial page.

Latest updates to the PD-L1+ Lung Cancer: Pembrolizumab vs Chemotherapy Clinical Trial page
- Check4 days agoChange DetectedRevision updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check12 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3. No visible changes to study details or page content.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedRevision v3.4.2 was added and the government funding notice was removed; Revision v3.4.1 was deleted. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check47 days agoChange DetectedA system-wide funding notice about NIH operations was added. The site revision tag was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check54 days agoChange DetectedShow glossary UI has been added and there are small labeling/capitalization tweaks (e.g., QC criteria label, FEAR Act data). The site revision has been updated from v3.3.4 to v3.4.0.SummaryDifference0.2%

- Check68 days agoChange DetectedThe page shows a minor revision update (Revision: v3.3.4) replacing the previous v3.3.3. No substantive changes to study details or page layout were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to PD-L1+ Lung Cancer: Pembrolizumab vs Chemotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-L1+ Lung Cancer: Pembrolizumab vs Chemotherapy Clinical Trial page.